Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 86 clinical trials
Featured trial
Type 2 Diabetes Study – Seeking Volunteers Who Treat with Any Combination of Medications, Except Insulin.

(Farxiga, Invokana, or Jardiance.)TZDs (Avandia, Actos, or Rezulin.)Alpha-glucosidase inhibitors (Precose, Glyset, or Voglibose.)Oral or injectable GLP-1 RAs (Byetta

  • 136 views
  • 08 Oct, 2021
  • 1 location
Featured trial
Do You Take Two Insulins to Treat Your Type 2 Diabetes?

other oral diabetes medications. They can also be taking injectable GLP-1 medications and qualify. Medications need to be stable for 90 days.) Qualifying Insulins

hemoglobin a1c
sugars
insulin
continuous glucose monitoring
metformin
  • 24 views
  • 22 Oct, 2021
  • 1 location
Featured trial
LixiLan-G EFC13794

LixiLan-G EFC13794

  • 644 views
  • 08 Nov, 2020
  • 1 location
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) (GAPP-SVD)

Cerebral small vessel disease (cSVD), a result of neurovascular cell dysfunction, is a major cause of stroke, dementia and mobility problems worldwide. Vascular risk factor control alone may not be sufficient to prevent the development of vascular cognitive impairment (VCI) in patients with cSVD according to previous clinical trials. The …

  • 0 views
  • 04 Oct, 2022
  • 1 location
Glucagon-like Peptide-1 in Type 1 Diabetes

The hypotheses to be tested in this application is: GLP-1 will acutely protect arterial endothelial function and reduce pro-atherothrombotic and pro-coagulant effects of repeated hypoglycemia in

  • 0 views
  • 27 Apr, 2022
  • 1 location
A Study of TG103 Injection in Overweight or Obesity

levels of TG103 injection, a GLP-1 receptor agonist, in the management of overweight or obesity, to support dose selection for further development.

  • 30 views
  • 06 Jun, 2022
  • 1 location
Laxative Properties of Microencapsulated Lipid (Constipation Study)

interventions (including GLP-1 analogues or bariatric surgery) to both avoid/treat constipation and simultaneously optimise their ability to feel full during eating. This potential dual action may provide added

lactulose
Accepts healthy volunteers
other laxatives
chronic constipation
laxative
  • 15 views
  • 13 Jun, 2022
  • 1 location
INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi

(FRC) of a basal insulin and a glucagon-like peptide-1 receptor agonist (GLP-1 RA), which can offer similar efficacy in glucose control with lower rates of hypoglycemia and smaller weight gain that

  • 0 views
  • 31 Jul, 2021
  • 1 location
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

The study will test: whether estrogen treatment in transwomen is associated with improved insulin sensitivity and beta cell function whether testosterone treatment in transmen is associated with worsening insulin sensitivity and beta cell function whether estrogen therapy leads to enhanced immune response in older transwormen

Accepts healthy volunteers
  • 24 views
  • 23 Mar, 2022
  • 1 location
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

The study is a prospective randomized study to examine the effects of exposure to dulaglutide on the prevention of stress-hyperglycemia and the metabolic inflammatory response in the perioperative period

  • 0 views
  • 04 Oct, 2022
  • 3 locations